NCT02122913 2026-02-05
A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer
Bayer
Phase 1 Completed
Bayer
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
Juno Therapeutics, a Subsidiary of Celgene
Novartis
Daiichi Sankyo
Merck Sharp & Dohme LLC
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Hoffmann-La Roche
Novartis